IU Health seeks to close several streets on expanded campus, feature open green space
The hospital system has filed a petition for vacation of several streets, meaning it wants to close or privatize them and fold them into the new campus.
Life Science & Biotech
Articles
Elanco to cut 900 jobs in 40 countries following Bayer acquisition
The layoff is the first step in what is expected to be a major restructuring following Greenfield-based Elanco’s $6.9 billion acquisition of German conglomerate Bayer AG’s animal-health division.
Catholic hospital giant Ascension suffers $1 billion yearly loss
Like many other providers, Ascension suspended all elective, nonessential medical and surgical procedures for several months to prepare for the surge of COVID-19 patients, reducing volume and revenue.
New rehab hospital planned for western region of Indianapolis
The joint-venture announcement by partners Community Health Network and Kindred Healthcare comes less than a month after the partners closed another rehabilitation hospital, Community Howard Specialty Hospital and Replay Physical Therapy in Kokomo.
Lilly’s Jardiance pill could get boost to blockbuster status with latest findings
Lilly and partner Boehringer Ingelheim published results from a trial showing the drug cut the risk of cardiovascular hospitalizations or death by 25%, compared to placebo in heart failure patients.
Indiana shakes up COVID-19 data by including antigen testing
Starting Monday, the state began including positive results from antigen tests along with its traditional PCR tests. That single move reduced the state’s testing-positivity rate—but some officials say the accuracy of antigen testing is still widely unknown.
Health products startup says its topical treatment can thwart coronavirus
Advanced Penetration Technology LLC said London-based research laboratory Virology Research Services evaluated the anti-viral impact of the product and concluded it is a “highly effective formulation” against the coronavirus.
Indiana hospitals starting to fill ICU beds again
The availability of ICU beds has fallen in recent weeks as hospitals have deactivated hundreds of beds while the number of COVID-19 hospitalizations has climbed.
Indiana’s largest nursing home operator has seen at least 374 COVID-19 deaths
Almost a quarter of the nursing home deaths from COVID-19 in Indiana have occurred at facilities operated by Health and Hospital Corporation of Marion County. The facilities are managed by Indianapolis-based American Senior Communities.
IU researcher’s latest biotech startup raises $34.6M
Carmel-based MBX Biosciences Inc., co-founded by serial entrepreneur Richard DiMarchi, aims to develop therapeutics to treat rare endocrine disorders.
Hoosiers feeling anxious, depressed over COVID-19 pandemic
In direct response to the high levels of stress and anxiety due to the pandemic, Indiana officials on Monday launched a crisis hotline, which will allow Hoosiers to speak confidentially with a trained counselor at any hour free of charge.
New disease? No problem. Regenstrief has new codes to help sort through COVID-19
The codes are critical to help track the virus by allowing health systems and public health officials around the world seamlessly exchange information.
Indiana sees number of COVID-19 cases climb, reversing weeks of downward trend
The increase is hitting more young people. People under 30 now account for 22% of all who have tested positive for COVID-19 in Indiana, up from 15% just a few weeks ago.
Novartis unit to build plant for targeted cancer drugs in Indianapolis
A subsidiary of Swiss drug giant Novartis AG announced plans Tuesday to build a targeted radioligand therapy plant at Purdue Research Park near Indianapolis International Airport.
Indiana-based pharmacy business building $2.7M center in Plainfield
In Touch Pharmaceuticals serves long-term-care facilities in Illinois, Indiana and Michigan. It credits its system for helping clients reduce medication errors, cut waste and reduce costs.
After years of turmoil, biotech testing firm aims to grow again
West Lafayette-based Bioanalytical Systems’ latest executive departure comes amid recent signs of stability, turnaround and growth for a company that just three years ago was on the verge of sinking.
Bayer to pay up to $10.9 billion to settle Roundup cases
The pharmaceutical company said the Roundup settlement would “bring closure to approximately 75%” of the current 125,000 claims against subsidiary Monsanto.
Indiana’s No. 6 rank in pharmaceutical jobs could provide boost during recovery
The Hoosier state has 17,093 industry jobs spread out among 69 companies, from Indianapolis-based drugmaker Eli Lilly and Co. to startups scattered around the state, but mostly in clusters near research universities.
Anthem sued for denying claims for electrical stimulation to treat pain
The Indianapolis-based insurer says the treatments are “investigational”—or still under clinical study—but a California woman claims the electrical stimulation is FDA-approved and supported by numerous studies.
Lilly’s hot-selling drug Taltz gets FDA approval for fifth use
Taltz rang up sales of $1.3 billion last year, an increase of 46%, making it Lilly’s fastest-growing drug. An estimated 137,000 patients have been treated with Taltz worldwide since its launch four years ago.